February 27, 2021
Business News

Sapreme Appoints Henrik Luessen as Chief Business Officer

UTRECHT, The Netherlands–()–Sapreme, a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutics, today announced the appointment of Henrik L. Luessen, Ph.D., as Chief Business Officer. In this role, Dr. Luessen will advise Sapreme in its business development, partnerships and funding activities, and will report to Guy Hermans, Ph.D., Chief Executive Officer.

“Henrik brings strong experience with emerging biotechnology companies to Sapreme including licensing, portfolio strategy, financing and strategic development which are critical aspects for Sapreme at this stage of development,” commented Guy Hermans, Chief Executive Officer of Sapreme. “Over the past year,…

Click here to view the original article.

Related Posts

You might also like ...

Strategy Analytics: Operating Systems for Autonomous Driving Face a Technology and Methodology Transition
OSFI discussion paper looks at climate-related risks for pension plans
New Study Published in Cephalalgia Identifies Mechanistic Differences Among CGRP Migraine Treatments